Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2017

May 9, 2017

284_dirs_2017-05-09_52cce0c7-fb2b-4e84-8109-e65973d5aab4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2017-05-05

Reporting Person: Karachun Rita A (Sr. VP Fince-Global Controller)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-05-09 Common Stock M 2576.0000 $0.0000 Acquired 17067.9720 Direct
2017-05-09 Common Stock F 960.0000 $64.0100 Disposed 16107.9720 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-05-05 Restricted Stock Unit $ A 3283.0000 Acquired 2020-05-05 Common Stock (3283.0000) Direct
2017-05-05 Stock Option (right to buy) $63.9700 A 29957.0000 Acquired 2027-05-04 Common Stock (29957.0000) Direct
2017-05-09 Restricted Stock Unit $ M 2576.0000 Disposed 2017-05-09 Common Stock (2576.0000) Direct

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F3: The option vests and becomes exercisable in three equal instllments on 5/5/2018, 5/5/2019 and 5/5/2020.